(S)-3(2h)-Pyridazinone, 6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl- Chemical Properties

InChI

InChI=1S/C11H13N3O/c1-7-6-10(15)13-14-11(7)8-2-4-9(12)5-3-8/h2-5,7H,6,12H2,1H3,(H,13,15)/t7-/m0/s1

InChIKey

GDMRFHZLKNYRRO-ZETCQYMHSA-N

SMILES

C1(=O)NN=C(C2=CC=C(N)C=C2)[C@@H](C)C1

(S)-3(2h)-Pyridazinone, 6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl- Usage And Synthesis

Uses

(5S)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone is an intermediate in the synthesis of Dextrosimendan (D299550), an isomer and impurity of Levosimendan (L378000), a bioactive enantiomer of Simendan (S466000). Levosimendan is a positive inotropic agent with vasodilating activity.

(S)-3(2h)-Pyridazinone, 6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl-(101328-84-1)Related Product Information

• Levosimendan
• Levosimendan Impurity 14
• LEVODOPA RELATED COMPOUND A (50 MG) (3-(3,4,6-TRIHYDROXYPHENYL)-ALANINE)
• diethyl 2-(1-(4-acetaMidophenyl)-1-oxopropan-2-yl)Malonate
• 3(2H)-Pyridazinone, 4,5-dihydro-5-methyl-6-phenyl-, (5R)-
• 4-(4-Aminophenyl)-3-methyl-4-oxobutanoic acid
• N-[4-(1-oxopropyl)phenyl]acetamide
• 4-METHYL-3,4-DIHYDROQUINOLIN-2(1H)-ONE
• Acetic acid, 2-cyano-2-[2-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]hydrazinylidene]-, ethyl ester
• Levosimendan-001
• N-[4-(2-bromopropanoyl)phenyl]acetamide
• Levosimendan Impurity 8
• Simendan
• 2-[2-[4-(2-Azidotetrahydro-3-Methyl-5-oxo-2-furanyl)phenyl]hydrazinylidene]propanedinitrile (Mixture of DiasteroMers)
• (R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone
• Levosimendan Impurity 16
• 3(2H)-Pyridazinone, 6-[4-(ethylamino)phenyl]-4,5-dihydro-5-methyl-
• 4-Amino-6-ethoxy-5-[[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]azo]-α-[[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]hydrazono]-2-pyrimidineacetonitrile